Stanley Laman Group Ltd. trimmed its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 5.4% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 5,404 shares of the healthcare conglomerate’s stock after selling 308 shares during the quarter. Stanley Laman Group Ltd.’s holdings in UnitedHealth Group were worth $1,346,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Chemical Bank increased its stake in UnitedHealth Group by 6.8% during the 4th quarter. Chemical Bank now owns 16,974 shares of the healthcare conglomerate’s stock worth $4,229,000 after purchasing an additional 1,075 shares in the last quarter. HL Financial Services LLC grew its stake in shares of UnitedHealth Group by 77.5% during the 4th quarter. HL Financial Services LLC now owns 30,498 shares of the healthcare conglomerate’s stock worth $7,598,000 after acquiring an additional 13,315 shares in the last quarter. Whittier Trust Co. of Nevada Inc. grew its stake in shares of UnitedHealth Group by 5.4% during the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 26,459 shares of the healthcare conglomerate’s stock worth $6,592,000 after acquiring an additional 1,356 shares in the last quarter. Whittier Trust Co. grew its stake in shares of UnitedHealth Group by 1.6% during the 4th quarter. Whittier Trust Co. now owns 70,049 shares of the healthcare conglomerate’s stock worth $17,451,000 after acquiring an additional 1,098 shares in the last quarter. Finally, InterOcean Capital LLC grew its stake in shares of UnitedHealth Group by 18.0% during the 4th quarter. InterOcean Capital LLC now owns 6,352 shares of the healthcare conglomerate’s stock worth $1,582,000 after acquiring an additional 969 shares in the last quarter. 85.80% of the stock is owned by institutional investors and hedge funds.

Several equities analysts have recently weighed in on UNH shares. Oppenheimer raised their price target on shares of UnitedHealth Group from $295.00 to $300.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 28th. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, December 18th. Cleveland Research reaffirmed a “buy” rating on shares of UnitedHealth Group in a research note on Friday, January 11th. Argus raised their price target on shares of UnitedHealth Group from $285.00 to $295.00 and gave the stock a “buy” rating in a research note on Monday, December 17th. Finally, Credit Suisse Group reaffirmed a “buy” rating and set a $310.00 price target on shares of UnitedHealth Group in a research note on Friday, February 8th. Two analysts have rated the stock with a hold rating and twenty-one have assigned a buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $297.80.

NYSE UNH opened at $251.40 on Friday. The company has a market capitalization of $243.06 billion, a PE ratio of 19.52, a P/E/G ratio of 1.26 and a beta of 0.79. The company has a debt-to-equity ratio of 0.64, a current ratio of 0.73 and a quick ratio of 0.73. UnitedHealth Group Inc has a 12 month low of $212.49 and a 12 month high of $287.94.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, January 15th. The healthcare conglomerate reported $3.28 EPS for the quarter, beating the consensus estimate of $3.20 by $0.08. The company had revenue of $58.42 billion during the quarter, compared to the consensus estimate of $58.01 billion. UnitedHealth Group had a return on equity of 24.38% and a net margin of 5.30%. The firm’s revenue for the quarter was up 12.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.59 EPS. On average, sell-side analysts forecast that UnitedHealth Group Inc will post 14.62 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th will be issued a $0.90 dividend. This represents a $3.60 annualized dividend and a dividend yield of 1.43%. The ex-dividend date is Friday, March 8th. UnitedHealth Group’s payout ratio is presently 27.95%.

In other news, Director Richard T. Burke sold 15,000 shares of the stock in a transaction that occurred on Thursday, January 17th. The stock was sold at an average price of $260.55, for a total value of $3,908,250.00. Following the completion of the sale, the director now owns 193,872 shares of the company’s stock, valued at approximately $50,513,349.60. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction that occurred on Tuesday, January 22nd. The shares were sold at an average price of $266.61, for a total value of $1,333,050.00. Following the completion of the sale, the director now directly owns 77,702 shares of the company’s stock, valued at approximately $20,716,130.22. The disclosure for this sale can be found here. In the last three months, insiders sold 27,930 shares of company stock valued at $7,208,783. 0.87% of the stock is currently owned by insiders.

TRADEMARK VIOLATION NOTICE: “Stanley Laman Group Ltd. Lowers Position in UnitedHealth Group Inc (UNH)” was originally published by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another publication, it was stolen and reposted in violation of US and international trademark & copyright laws. The correct version of this article can be viewed at https://www.watchlistnews.com/stanley-laman-group-ltd-lowers-position-in-unitedhealth-group-inc-unh/2897069.html.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Article: What are retained earnings?

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.